Kim Falkenberg

I am responsible for validating potential metabolic targets for anti-angiogenic therapies. Coordinting a small flexible team, I am designing goal-oriented experimental strategies for high-quality data generation and organise them with expert technicians/facilities or visiting researchers. My position also entails the critical assessment of scientific studies by peer-reviewing manuscripts, as well as conveying key concepts of my field to non-experts in an engaging manner by writing literature reviews.

The objective of my project was to reveal the unknown cause of genetic peroxisomal diseases. Organizing myself independently (in the framework of projected deliverables, incl. progress reports) and in collaboration with international institutions (e.g. by short research visits abroad), I successfully identified three novel diseases or disease mechanisms, all of which published in peer-reviewed journals. I was also granted the opportunity to present my findings at international conferences (see Awards).

Research visit as Early Stage Researcher in laboratory of Damien Devos (Centro Andaluz de Biología del Desarrollo) Accomplishments: successful integrative structural analysis of genetic mutations in peroxisomal proteins & in silico prediction of protein / domain functions

Research visit as Early Stage Researcher in laboratory of Michael Schrader (Department of Biosciences) Accomplishments: optimization of immunofluorescence assays; exchange of knowledge regarding mammalian cell culture techniques for peroxisomal studies

Identification & Characterisation of Novel Peroxisomal Disorders